All Stories

  1. Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis

    Article • Journal of Dermatological Treatment, July 2019, Taylor & Francis

    Andreas Pinter

  2. Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review

    Article • Clinical Cosmetic and Investigational Dermatology, July 2019, Dove Medical Press

    Andreas Pinter

  3. Adiponectin levels in a large pooled plaque psoriasis study population

    Article • Journal of Dermatological Treatment, June 2019, Taylor & Francis

    Andreas Pinter

  4. Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial

    Article • Journal of Dermatological Treatment, February 2019, Taylor & Francis

    Andreas Pinter

  5. Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature

    Article • Clinical Cosmetic and Investigational Dermatology, October 2018, Dove Medical Press

    Andreas Pinter

  6. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism

    Article • Experimental Dermatology, January 2017, Wiley

    Andreas Pinter

  7. Frankfurter Dermatologentagung – 11. November 2015, Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main

    Article • Aktuelle Dermatologie, December 2015, Thieme Publishing Group

    Andreas Pinter